Aller au contenu principal
Profil bibliographique

Yuanhui Gu

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées
352Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Gastrointestinal Tumor Research and TreatmentGastric Cancer Management and OutcomesGallbladder and Bile Duct DisordersImmune cells in cancerGastrointestinal disorders and treatments

Les publications récentes

Accès ouvert 2025 article OpenAlex

GCN5L: a critical target in energy metabolism pathways

Yushun Kou, Rui Ma, Yiyuan Wang, Xiaojie Chen et autres

GCN5L (GCN5-like protein), as a core component of a novel epigenetic-regulatory complex, exerts precise control over mitochondrial metabolic enzyme activity through acetylation modifications. It not only drives energy production but also regulates key processes like lipid metabolism and cellular stress responses. As …

cn (code pays fourni par la source)

0 citations Frontiers in Cell and Developmental Biology
Accès ouvert 2025 article OpenAlex

Correlation between dyslipidaemia and gastric cancer: pathogenesis to prevention and treatment strategies

Tao Wu, Lingna Zhang, Jiao Tian, Yuyuan Lu et autres

As the sixth most common cancer in the world, the development of gastric cancer (GC) is influenced by many factors. Recent studies have revealed a strong association between dyslipidaemia and GC. In this paper, the relationships between dyslipidaemia and GC are discussed …

cn (code pays fourni par la source)

0 citations Lipids in Health and Disease
Accès ouvert 2025 article OpenAlex

Pathologic complete response after Sintilimab combined with FOLFOX therapy in MSI-H type patients with locally advanced GC: a case report

Yuanhui Gu, Yi Lin, Tao Wu, Ling Wang et autres

As one of the most common gastrointestinal tumors, Gastric Cancer (GC) poses a serious threat to human health due to its high morbidity and mortality. The current treatment strategy is a comprehensive treatment program mainly based on surgery, especially for advanced GC …

cn (code pays fourni par la source)

1 citation Frontiers in Oncology
Accès ouvert 2025 book-review OpenAlex

Meta-analysis of the efficacy of applying reduced surgery for the treatment of asymptomatic unresectable advanced gastric cancer

Xiong Li, Ting Lei, Liangyin Fu, Ruiyu Gao et autres

OBJECTIVES: Systematic evaluation of the efficacy and safety of reduction surgery in asymptomatic unresectable advanced gastric cancer. MATERIALS AND METHODS: PubMed, EMBASE, Cochrane Library and Web of Science were searched from database inception to 12 July 2024. The Cochrane Risk of Bias …

cn (code pays fourni par la source)

0 citations BMC Gastroenterology
Accès ouvert 2024 article OpenAlex

Mechanisms and treatment of atherosclerosis: focus on macrophages

Jiawei Li, Hong Wang, Rui Ma, Tao Wu et autres

Macrophages are the basic mediators and coordinators of various types of chronic inflammation and play a crucial role in the formation and development of atherosclerosis (AS). In the complex microenvironment of atherosclerotic plaques, macrophages of different sources are exposed to different signal …

cn (code pays fourni par la source)

37 citations Frontiers in Immunology
Accès ouvert 2024 article OpenAlex

Two different mutational types of familial gastrointestinal stromal tumors: Two case reports

Xiaoke Wang, Lu-Fan Shen, Xin Yang, He Su et autres

BACKGROUND: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract, and cases of GISTs tend to be of the disseminated type, with a global incidence of 10 to 15 cases/million each year. The rarer familial GISTs, …

cn (code pays fourni par la source)

1 citation World Journal of Gastrointestinal Oncology
Accès ouvert 2024 article OpenAlex

Advances in immunotherapy of M2 macrophages and gastrointestinal stromal tumor

Xiaoke Wang, Xin Yang, Tong-Han Yao, Pengxian Tao et autres

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal-derived tumors of the GI tract. They can occur throughout the GI tract, and the survival time of some patients can be improved by first-line targeted therapy with imatinib. However, there are some limitations …

cn (code pays fourni par la source)

2 citations World Journal of Gastrointestinal Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.